Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression - A Free Webinar from the Brain & Behavior Research Foundation
04 mai 2021 09h00 HE | Brain & Behavior Research Foundation
New York, May 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Using Rapid-Acting Brain Stimulation for Treatment-Resistant Depression” on...
logo.png
Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland
29 avr. 2021 03h00 HE | Nexstim Oyj
Press Release, Helsinki, 29 April 2021 at 10:00 AM (EEST) Nexstim Receives an NBT® System Order from a New Therapy Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
logo.png
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
16 avr. 2021 05h00 HE | Nexstim Oyj
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX,...
22157.jpg
Outlook on the Precision Psychiatry Global Market to 2026 - Increasing Adoption of Inorganic Growth Strategies is Driving Growth
09 avr. 2021 07h58 HE | Research and Markets
Dublin, April 09, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Psychiatry Market: Focus on Product Type, Biomarker, Sample, Technology, Applications, End Users, Country Data (15 Countries), and...
Addiction: Science Drives New & Novel Treatments - A Free Webinar from the Brain & Behavior Research Foundation
30 mars 2021 09h00 HE | Brain & Behavior Research Foundation
New York, March 30, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Addiction: Science Drives New & Novel Treatments” on Tuesday, April...
logo.png
Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder
12 mars 2021 03h00 HE | Nexstim Oyj
Press Release, Helsinki, 12 March 2021 at 10.00 (EET) Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or...
Headstrong Project Inc., Announces Two-Year Investment from the Robert R. McCormick Foundation, Expanding Care to U.S. Veterans within Vulnerable Regions in Chicagoland Area
11 mars 2021 08h00 HE | The Headstrong Project
New York, NY, March 11, 2021 (GLOBE NEWSWIRE) -- Headstrong Project Inc., a national-facing mental health treatment practice providing veterans with barrier-free mental health care, received a...
wmp_logo.png
Psychiatrist Tells All with March 5 Launch of Book “Wounded Workers”
03 mars 2021 17h41 HE | Working Man's Press
SANTA FE, N.M., March 03, 2021 (GLOBE NEWSWIRE) -- Now available on Amazon Books, “Wounded Workers” from Working Man's Press is Dr. Bob Larsen’s first book intended for an audience of folks who have...
Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital
03 mars 2021 02h00 HE | Nexstim Oyj
Company announcement, Inside information, Helsinki, 3 March 2021 at 9.00 am (EET)  Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University...
Nexstim Oyj esittää rohkaisevat tulokset Kuopion yliopistollisen sairaalaan vakavan masennuksen hoidon alustavasta pilottitutkimuksesta
03 mars 2021 02h00 HE | Nexstim Oyj
Yhtiötiedote, sisäpiiritieto, Helsinki, 3.3.2021 klo 9.00 (EET)    Nexstim Oyj esittää rohkaisevat tulokset Kuopion yliopistollisen sairaalaan vakavan masennuksen hoidon alustavasta...